Our own recent experiments suggest that PROG may upregulate the expression of endogenous tPA and extend its window of effectiveness up to at least, 6 hours, but this will need to be confirmed by further research.9 As of

this writing, no clinical trials using PROG or its metabolites are being planned for stroke patients. There is Inhibitors,research,lifescience,medical now evidence that PROG and some of its metabolites may be beneficial for other neurodegenerative disorders. Over the last, 10 years, several groups have reported that PROG exerts beneficial effects in spinal cord injury, including enhanced remyelination and improved motor function.21,46-50 In a streptozotocininduced diabetic neuropathy model in rat, Leonelli et al51 showed that treatment with PROG and some of its metabolites sustains nerve conduction velocity, restores skin innervation, and maintains sensitivity to thermal stimulation. Treatment with various allopregnanolonc Inhibitors,research,lifescience,medical (ALLO; a metabolite of PROG) regimens in an animal model of Niemann-Pick type C disease, an irreversibly fatal developmental neurodegenerative illness, may delay the onset of symptoms (tremor, ataxia, GDC-0068 research buy weight loss).52-54 Another neurodegenerative condition, experimental autoimmune Inhibitors,research,lifescience,medical encephalomyelitis (RAF,), a model of multiple sclerosis,

may be amenable to treatment with PROG or its metabolites.55 From a psychiatric perspective Inhibitors,research,lifescience,medical there are some additional advantages to considering PROG and its metabolites as therapeutic agents following brain injury caused by trauma or stroke. Both PROG and ALLO are present, in the serum and brain. ALLO is metabolized when PROG is converted to dihydroprogesterone by 5α-reductase and then into ALLO by 3α;-hydroxysteroid dehydrogenase. ALLO is being evaluated because of its effects on the expression and release Y-amin°butyric acid (GABA)a, an inhibitory neurotransmitter which can block or reduce post-injury seizure activity and its resultant excitotoxicity.56 ALLO but, not PROG is thought

Inhibitors,research,lifescience,medical to act directly as a ligand for the GABAa receptor and some of its isoforms.56,57 A major component of TBI and Cediranib (AZD2171) stroke is depression and anxiety,58-61 and there is growing evidence that administration of PROG and ALLO may play a role in reducing TBI-related symptoms in animal models of these disorders. The anxiolytic and antidepressant effects of PROG and ALLO can even be observed in progesterone receptor (PR) knockout mouse models, suggesting that the classical PRs are not necessarily implicated directly in the beneficial outcomes of the treatment.62 However, others have claimed that when some PR antagonists have been used, depression-like behaviors will become more obvious,63 so the issue may be more complex than one might, think.